The global market for Prostate Cancer Therapeutics Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Therapeutics Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Prostate Cancer Therapeutics Drugs by region & country, by Type, and by Sale Channel.

The Prostate Cancer Therapeutics Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Therapeutics Drugs.

Market Segmentation

Scope of Prostate Cancer Therapeutics Drugs - Market Report

Report Metric	Details
Report Name	Prostate Cancer Therapeutics Drugs - Market
CAGR	5%
Segment by Type:	Hormone Therapy Chemotherapy Biologic Therapy Targeted Therapy Other
Segment by Sale Channel	Hospital Pharmacy Retail Pharmacy Online Sales Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Johnson & Johnson, Pfizer, Inc, AstraZeneca, Amgen, Inc, AbbVie, Inc, Bayer AG, Ipsen Group, Sanofi, Endo Pharmaceuticals, Dendreon Corporation
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Prostate Cancer Therapeutics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Prostate Cancer Therapeutics Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Prostate Cancer Therapeutics Drugs in country level. It provides sigmate data by Type, and by Sale Channel for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Prostate Cancer Therapeutics Drugs - Market report?

Ans: The main players in the Prostate Cancer Therapeutics Drugs - Market are Johnson & Johnson, Pfizer, Inc, AstraZeneca, Amgen, Inc, AbbVie, Inc, Bayer AG, Ipsen Group, Sanofi, Endo Pharmaceuticals, Dendreon Corporation

What are the Type segmentation covered in the Prostate Cancer Therapeutics Drugs - Market report?

Ans: The Types covered in the Prostate Cancer Therapeutics Drugs - Market report are Hormone Therapy, Chemotherapy, Biologic Therapy, Targeted Therapy, Other

1 Market Overview

1.1 Prostate Cancer Therapeutics Drugs Product Introduction

1.2 Global Prostate Cancer Therapeutics Drugs Market Size Forecast

1.2.1 Global Prostate Cancer Therapeutics Drugs Sales Value (2019-2030)

1.2.2 Global Prostate Cancer Therapeutics Drugs Sales Volume (2019-2030)

1.2.3 Global Prostate Cancer Therapeutics Drugs Sales Price (2019-2030)

1.3 Prostate Cancer Therapeutics Drugs Market Trends & Drivers

1.3.1 Prostate Cancer Therapeutics Drugs Industry Trends

1.3.2 Prostate Cancer Therapeutics Drugs Market Drivers & Opportunity

1.3.3 Prostate Cancer Therapeutics Drugs Market Challenges

1.3.4 Prostate Cancer Therapeutics Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Prostate Cancer Therapeutics Drugs Players Revenue Ranking (2023)

2.2 Global Prostate Cancer Therapeutics Drugs Revenue by Company (2019-2024)

2.3 Global Prostate Cancer Therapeutics Drugs Players Sales Volume Ranking (2023)

2.4 Global Prostate Cancer Therapeutics Drugs Sales Volume by Company Players (2019-2024)

2.5 Global Prostate Cancer Therapeutics Drugs Average Price by Company (2019-2024)

2.6 Key Manufacturers Prostate Cancer Therapeutics Drugs Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Prostate Cancer Therapeutics Drugs Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Prostate Cancer Therapeutics Drugs

2.9 Prostate Cancer Therapeutics Drugs Market Competitive Analysis

2.9.1 Prostate Cancer Therapeutics Drugs Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Prostate Cancer Therapeutics Drugs Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Therapeutics Drugs as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Hormone Therapy

3.1.2 Chemotherapy

3.1.3 Biologic Therapy

3.1.4 Targeted Therapy

3.1.5 Other

3.2 Global Prostate Cancer Therapeutics Drugs Sales Value by Type

3.2.1 Global Prostate Cancer Therapeutics Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Prostate Cancer Therapeutics Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Prostate Cancer Therapeutics Drugs Sales Value, by Type (%) (2019-2030)

3.3 Global Prostate Cancer Therapeutics Drugs Sales Volume by Type

3.3.1 Global Prostate Cancer Therapeutics Drugs Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Prostate Cancer Therapeutics Drugs Sales Volume, by Type (2019-2030)

3.3.3 Global Prostate Cancer Therapeutics Drugs Sales Volume, by Type (%) (2019-2030)

3.4 Global Prostate Cancer Therapeutics Drugs Average Price by Type (2019-2030)

4 Segmentation by Sale Channel

4.1 Introduction by Sale Channel

4.1.1 Hospital Pharmacy

4.1.2 Retail Pharmacy

4.1.3 Online Sales

4.1.4 Other

4.2 Global Prostate Cancer Therapeutics Drugs Sales Value by Sale Channel

4.2.1 Global Prostate Cancer Therapeutics Drugs Sales Value by Sale Channel (2019 VS 2023 VS 2030)

4.2.2 Global Prostate Cancer Therapeutics Drugs Sales Value, by Sale Channel (2019-2030)

4.2.3 Global Prostate Cancer Therapeutics Drugs Sales Value, by Sale Channel (%) (2019-2030)

4.3 Global Prostate Cancer Therapeutics Drugs Sales Volume by Sale Channel

4.3.1 Global Prostate Cancer Therapeutics Drugs Sales Volume by Sale Channel (2019 VS 2023 VS 2030)

4.3.2 Global Prostate Cancer Therapeutics Drugs Sales Volume, by Sale Channel (2019-2030)

4.3.3 Global Prostate Cancer Therapeutics Drugs Sales Volume, by Sale Channel (%) (2019-2030)

4.4 Global Prostate Cancer Therapeutics Drugs Average Price by Sale Channel (2019-2030)

5 Segmentation by Region

5.1 Global Prostate Cancer Therapeutics Drugs Sales Value by Region

5.1.1 Global Prostate Cancer Therapeutics Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Prostate Cancer Therapeutics Drugs Sales Value by Region (2019-2024)

5.1.3 Global Prostate Cancer Therapeutics Drugs Sales Value by Region (2025-2030)

5.1.4 Global Prostate Cancer Therapeutics Drugs Sales Value by Region (%), (2019-2030)

5.2 Global Prostate Cancer Therapeutics Drugs Sales Volume by Region

5.2.1 Global Prostate Cancer Therapeutics Drugs Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Prostate Cancer Therapeutics Drugs Sales Volume by Region (2019-2024)

5.2.3 Global Prostate Cancer Therapeutics Drugs Sales Volume by Region (2025-2030)

5.2.4 Global Prostate Cancer Therapeutics Drugs Sales Volume by Region (%), (2019-2030)

5.3 Global Prostate Cancer Therapeutics Drugs Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Prostate Cancer Therapeutics Drugs Sales Value, 2019-2030

5.4.2 North America Prostate Cancer Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Prostate Cancer Therapeutics Drugs Sales Value, 2019-2030

5.5.2 Europe Prostate Cancer Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Prostate Cancer Therapeutics Drugs Sales Value, 2019-2030

5.6.2 Asia Pacific Prostate Cancer Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Prostate Cancer Therapeutics Drugs Sales Value, 2019-2030

5.7.2 South America Prostate Cancer Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Prostate Cancer Therapeutics Drugs Sales Value, 2019-2030

5.8.2 Middle East & Africa Prostate Cancer Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Prostate Cancer Therapeutics Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Prostate Cancer Therapeutics Drugs Sales Value

6.2.1 Key Countries/Regions Prostate Cancer Therapeutics Drugs Sales Value, 2019-2030

6.2.2 Key Countries/Regions Prostate Cancer Therapeutics Drugs Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Prostate Cancer Therapeutics Drugs Sales Value, 2019-2030

6.3.2 United States Prostate Cancer Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Prostate Cancer Therapeutics Drugs Sales Value by Sale Channel, 2023 VS 2030

6.4 Europe

6.4.1 Europe Prostate Cancer Therapeutics Drugs Sales Value, 2019-2030

6.4.2 Europe Prostate Cancer Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Prostate Cancer Therapeutics Drugs Sales Value by Sale Channel, 2023 VS 2030

6.5 China

6.5.1 China Prostate Cancer Therapeutics Drugs Sales Value, 2019-2030

6.5.2 China Prostate Cancer Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Prostate Cancer Therapeutics Drugs Sales Value by Sale Channel, 2023 VS 2030

6.6 Japan

6.6.1 Japan Prostate Cancer Therapeutics Drugs Sales Value, 2019-2030

6.6.2 Japan Prostate Cancer Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Prostate Cancer Therapeutics Drugs Sales Value by Sale Channel, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Prostate Cancer Therapeutics Drugs Sales Value, 2019-2030

6.7.2 South Korea Prostate Cancer Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Prostate Cancer Therapeutics Drugs Sales Value by Sale Channel, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Prostate Cancer Therapeutics Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Prostate Cancer Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Prostate Cancer Therapeutics Drugs Sales Value by Sale Channel, 2023 VS 2030

6.9 India

6.9.1 India Prostate Cancer Therapeutics Drugs Sales Value, 2019-2030

6.9.2 India Prostate Cancer Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Prostate Cancer Therapeutics Drugs Sales Value by Sale Channel, 2023 VS 2030

7 Company Profiles

7.1 Johnson & Johnson

7.1.1 Johnson & Johnson Company Information

7.1.2 Johnson & Johnson Introduction and Business Overview

7.1.3 Johnson & Johnson Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Johnson & Johnson Prostate Cancer Therapeutics Drugs Product Offerings

7.1.5 Johnson & Johnson Recent Development

7.2 Pfizer, Inc

7.2.1 Pfizer, Inc Company Information

7.2.2 Pfizer, Inc Introduction and Business Overview

7.2.3 Pfizer, Inc Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Pfizer, Inc Prostate Cancer Therapeutics Drugs Product Offerings

7.2.5 Pfizer, Inc Recent Development

7.3 AstraZeneca

7.3.1 AstraZeneca Company Information

7.3.2 AstraZeneca Introduction and Business Overview

7.3.3 AstraZeneca Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)

7.3.4 AstraZeneca Prostate Cancer Therapeutics Drugs Product Offerings

7.3.5 AstraZeneca Recent Development

7.4 Amgen, Inc

7.4.1 Amgen, Inc Company Information

7.4.2 Amgen, Inc Introduction and Business Overview

7.4.3 Amgen, Inc Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Amgen, Inc Prostate Cancer Therapeutics Drugs Product Offerings

7.4.5 Amgen, Inc Recent Development

7.5 AbbVie, Inc

7.5.1 AbbVie, Inc Company Information

7.5.2 AbbVie, Inc Introduction and Business Overview

7.5.3 AbbVie, Inc Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)

7.5.4 AbbVie, Inc Prostate Cancer Therapeutics Drugs Product Offerings

7.5.5 AbbVie, Inc Recent Development

7.6 Bayer AG

7.6.1 Bayer AG Company Information

7.6.2 Bayer AG Introduction and Business Overview

7.6.3 Bayer AG Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Bayer AG Prostate Cancer Therapeutics Drugs Product Offerings

7.6.5 Bayer AG Recent Development

7.7 Ipsen Group

7.7.1 Ipsen Group Company Information

7.7.2 Ipsen Group Introduction and Business Overview

7.7.3 Ipsen Group Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Ipsen Group Prostate Cancer Therapeutics Drugs Product Offerings

7.7.5 Ipsen Group Recent Development

7.8 Sanofi

7.8.1 Sanofi Company Information

7.8.2 Sanofi Introduction and Business Overview

7.8.3 Sanofi Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Sanofi Prostate Cancer Therapeutics Drugs Product Offerings

7.8.5 Sanofi Recent Development

7.9 Endo Pharmaceuticals

7.9.1 Endo Pharmaceuticals Company Information

7.9.2 Endo Pharmaceuticals Introduction and Business Overview

7.9.3 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Product Offerings

7.9.5 Endo Pharmaceuticals Recent Development

7.10 Dendreon Corporation

7.10.1 Dendreon Corporation Company Information

7.10.2 Dendreon Corporation Introduction and Business Overview

7.10.3 Dendreon Corporation Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Dendreon Corporation Prostate Cancer Therapeutics Drugs Product Offerings

7.10.5 Dendreon Corporation Recent Development

8 Industry Chain Analysis

8.1 Prostate Cancer Therapeutics Drugs Industrial Chain

8.2 Prostate Cancer Therapeutics Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Prostate Cancer Therapeutics Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Prostate Cancer Therapeutics Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Prostate Cancer Therapeutics Drugs Market Trends

Table 2. Prostate Cancer Therapeutics Drugs Market Drivers & Opportunity

Table 3. Prostate Cancer Therapeutics Drugs Market Challenges

Table 4. Prostate Cancer Therapeutics Drugs Market Restraints

Table 5. Global Prostate Cancer Therapeutics Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Company (2019-2024)

Table 7. Global Prostate Cancer Therapeutics Drugs Sales Volume by Company (2019-2024) & (K Pcs)

Table 8. Global Prostate Cancer Therapeutics Drugs Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Prostate Cancer Therapeutics Drugs Price by Company (2019-2024) & (USD/Pcs)

Table 10. Key Manufacturers Prostate Cancer Therapeutics Drugs Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Prostate Cancer Therapeutics Drugs Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Prostate Cancer Therapeutics Drugs

Table 13. Global Prostate Cancer Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Therapeutics Drugs as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Prostate Cancer Therapeutics Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Prostate Cancer Therapeutics Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Prostate Cancer Therapeutics Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Prostate Cancer Therapeutics Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Prostate Cancer Therapeutics Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Prostate Cancer Therapeutics Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Pcs)

Table 22. Global Prostate Cancer Therapeutics Drugs Sales Volume by Type (2019-2024) & (K Pcs)

Table 23. Global Prostate Cancer Therapeutics Drugs Sales Volume by Type (2025-2030) & (K Pcs)

Table 24. Global Prostate Cancer Therapeutics Drugs Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Prostate Cancer Therapeutics Drugs Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Prostate Cancer Therapeutics Drugs Price by Type (2019-2024) & (USD/Pcs)

Table 27. Global Prostate Cancer Therapeutics Drugs Price by Type (2025-2030) & (USD/Pcs)

Table 28. Global Prostate Cancer Therapeutics Drugs Sales Value by Sale Channel: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Prostate Cancer Therapeutics Drugs Sales Value by Sale Channel (2019-2024) & (US$ Million)

Table 30. Global Prostate Cancer Therapeutics Drugs Sales Value by Sale Channel (2025-2030) & (US$ Million)

Table 31. Global Prostate Cancer Therapeutics Drugs Sales Market Share in Value by Sale Channel (2019-2024) & (%)

Table 32. Global Prostate Cancer Therapeutics Drugs Sales Market Share in Value by Sale Channel (2025-2030) & (%)

Table 33. Global Prostate Cancer Therapeutics Drugs Sales Volume by Sale Channel: 2019 VS 2023 VS 2030 (K Pcs)

Table 34. Global Prostate Cancer Therapeutics Drugs Sales Volume by Sale Channel (2019-2024) & (K Pcs)

Table 35. Global Prostate Cancer Therapeutics Drugs Sales Volume by Sale Channel (2025-2030) & (K Pcs)

Table 36. Global Prostate Cancer Therapeutics Drugs Sales Market Share in Volume by Sale Channel (2019-2024) & (%)

Table 37. Global Prostate Cancer Therapeutics Drugs Sales Market Share in Volume by Sale Channel (2025-2030) & (%)

Table 38. Global Prostate Cancer Therapeutics Drugs Price by Sale Channel (2019-2024) & (USD/Pcs)

Table 39. Global Prostate Cancer Therapeutics Drugs Price by Sale Channel (2025-2030) & (USD/Pcs)

Table 40. Global Prostate Cancer Therapeutics Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Prostate Cancer Therapeutics Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Prostate Cancer Therapeutics Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Prostate Cancer Therapeutics Drugs Sales Value by Region (2019-2024) & (%)

Table 44. Global Prostate Cancer Therapeutics Drugs Sales Value by Region (2025-2030) & (%)

Table 45. Global Prostate Cancer Therapeutics Drugs Sales Volume by Region (K Pcs): 2019 VS 2023 VS 2030

Table 46. Global Prostate Cancer Therapeutics Drugs Sales Volume by Region (2019-2024) & (K Pcs)

Table 47. Global Prostate Cancer Therapeutics Drugs Sales Volume by Region (2025-2030) & (K Pcs)

Table 48. Global Prostate Cancer Therapeutics Drugs Sales Volume by Region (2019-2024) & (%)

Table 49. Global Prostate Cancer Therapeutics Drugs Sales Volume by Region (2025-2030) & (%)

Table 50. Global Prostate Cancer Therapeutics Drugs Average Price by Region (2019-2024) & (USD/Pcs)

Table 51. Global Prostate Cancer Therapeutics Drugs Average Price by Region (2025-2030) & (USD/Pcs)

Table 52. Key Countries/Regions Prostate Cancer Therapeutics Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Prostate Cancer Therapeutics Drugs Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Prostate Cancer Therapeutics Drugs Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Prostate Cancer Therapeutics Drugs Sales Volume, (2019-2024) & (K Pcs)

Table 56. Key Countries/Regions Prostate Cancer Therapeutics Drugs Sales Volume, (2025-2030) & (K Pcs)

Table 57. Johnson & Johnson Company Information

Table 58. Johnson & Johnson Introduction and Business Overview

Table 59. Johnson & Johnson Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 60. Johnson & Johnson Prostate Cancer Therapeutics Drugs Product Offerings

Table 61. Johnson & Johnson Recent Development

Table 62. Pfizer, Inc Company Information

Table 63. Pfizer, Inc Introduction and Business Overview

Table 64. Pfizer, Inc Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 65. Pfizer, Inc Prostate Cancer Therapeutics Drugs Product Offerings

Table 66. Pfizer, Inc Recent Development

Table 67. AstraZeneca Company Information

Table 68. AstraZeneca Introduction and Business Overview

Table 69. AstraZeneca Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 70. AstraZeneca Prostate Cancer Therapeutics Drugs Product Offerings

Table 71. AstraZeneca Recent Development

Table 72. Amgen, Inc Company Information

Table 73. Amgen, Inc Introduction and Business Overview

Table 74. Amgen, Inc Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 75. Amgen, Inc Prostate Cancer Therapeutics Drugs Product Offerings

Table 76. Amgen, Inc Recent Development

Table 77. AbbVie, Inc Company Information

Table 78. AbbVie, Inc Introduction and Business Overview

Table 79. AbbVie, Inc Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 80. AbbVie, Inc Prostate Cancer Therapeutics Drugs Product Offerings

Table 81. AbbVie, Inc Recent Development

Table 82. Bayer AG Company Information

Table 83. Bayer AG Introduction and Business Overview

Table 84. Bayer AG Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 85. Bayer AG Prostate Cancer Therapeutics Drugs Product Offerings

Table 86. Bayer AG Recent Development

Table 87. Ipsen Group Company Information

Table 88. Ipsen Group Introduction and Business Overview

Table 89. Ipsen Group Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 90. Ipsen Group Prostate Cancer Therapeutics Drugs Product Offerings

Table 91. Ipsen Group Recent Development

Table 92. Sanofi Company Information

Table 93. Sanofi Introduction and Business Overview

Table 94. Sanofi Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 95. Sanofi Prostate Cancer Therapeutics Drugs Product Offerings

Table 96. Sanofi Recent Development

Table 97. Endo Pharmaceuticals Company Information

Table 98. Endo Pharmaceuticals Introduction and Business Overview

Table 99. Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 100. Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Product Offerings

Table 101. Endo Pharmaceuticals Recent Development

Table 102. Dendreon Corporation Company Information

Table 103. Dendreon Corporation Introduction and Business Overview

Table 104. Dendreon Corporation Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 105. Dendreon Corporation Prostate Cancer Therapeutics Drugs Product Offerings

Table 106. Dendreon Corporation Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Prostate Cancer Therapeutics Drugs Downstream Customers

Table 110. Prostate Cancer Therapeutics Drugs Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Prostate Cancer Therapeutics Drugs Product Picture

Figure 2. Global Prostate Cancer Therapeutics Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Prostate Cancer Therapeutics Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Prostate Cancer Therapeutics Drugs Sales Volume (2019-2030) & (K Pcs)

Figure 5. Global Prostate Cancer Therapeutics Drugs Sales Price (2019-2030) & (USD/Pcs)

Figure 6. Prostate Cancer Therapeutics Drugs Report Years Considered

Figure 7. Global Prostate Cancer Therapeutics Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Prostate Cancer Therapeutics Drugs Players Sales Volume Ranking (2023) & (K Pcs)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Prostate Cancer Therapeutics Drugs Revenue in 2023

Figure 10. Prostate Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Hormone Therapy Picture

Figure 12. Chemotherapy Picture

Figure 13. Biologic Therapy Picture

Figure 14. Targeted Therapy Picture

Figure 15. Other Picture

Figure 16. Global Prostate Cancer Therapeutics Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Prostate Cancer Therapeutics Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 18. Global Prostate Cancer Therapeutics Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Pcs)

Figure 19. Global Prostate Cancer Therapeutics Drugs Sales Volume Market Share by Type, 2023 & 2030

Figure 20. Global Prostate Cancer Therapeutics Drugs Price by Type (2019-2030) & (USD/Pcs)

Figure 21. Product Picture of Hospital Pharmacy

Figure 22. Product Picture of Retail Pharmacy

Figure 23. Product Picture of Online Sales

Figure 24. Product Picture of Other

Figure 25. Global Prostate Cancer Therapeutics Drugs Sales Value by Sale Channel (2019 VS 2023 VS 2030) & (US$ Million)

Figure 26. Global Prostate Cancer Therapeutics Drugs Sales Value Market Share by Sale Channel, 2023 & 2030

Figure 27. Global Prostate Cancer Therapeutics Drugs Sales Volume by Sale Channel (2019 VS 2023 VS 2030) & (K Pcs)

Figure 28. Global Prostate Cancer Therapeutics Drugs Sales Volume Market Share by Sale Channel, 2023 & 2030

Figure 29. Global Prostate Cancer Therapeutics Drugs Price by Sale Channel (2019-2030) & (USD/Pcs)

Figure 30. North America Prostate Cancer Therapeutics Drugs Sales Value (2019-2030) & (US$ Million)

Figure 31. North America Prostate Cancer Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030

Figure 32. Europe Prostate Cancer Therapeutics Drugs Sales Value (2019-2030) & (US$ Million)

Figure 33. Europe Prostate Cancer Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030

Figure 34. Asia Pacific Prostate Cancer Therapeutics Drugs Sales Value (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Prostate Cancer Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030

Figure 36. South America Prostate Cancer Therapeutics Drugs Sales Value (2019-2030) & (US$ Million)

Figure 37. South America Prostate Cancer Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030

Figure 38. Middle East & Africa Prostate Cancer Therapeutics Drugs Sales Value (2019-2030) & (US$ Million)

Figure 39. Middle East & Africa Prostate Cancer Therapeutics Drugs Sales Value by Country (%), 2023 VS 2030

Figure 40. Key Countries/Regions Prostate Cancer Therapeutics Drugs Sales Value (%), (2019-2030)

Figure 41. Key Countries/Regions Prostate Cancer Therapeutics Drugs Sales Volume (%), (2019-2030)

Figure 42. United States Prostate Cancer Therapeutics Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 43. United States Prostate Cancer Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

Figure 44. United States Prostate Cancer Therapeutics Drugs Sales Value by Sale Channel (%), 2023 VS 2030

Figure 45. Europe Prostate Cancer Therapeutics Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 46. Europe Prostate Cancer Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

Figure 47. Europe Prostate Cancer Therapeutics Drugs Sales Value by Sale Channel (%), 2023 VS 2030

Figure 48. China Prostate Cancer Therapeutics Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 49. China Prostate Cancer Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

Figure 50. China Prostate Cancer Therapeutics Drugs Sales Value by Sale Channel (%), 2023 VS 2030

Figure 51. Japan Prostate Cancer Therapeutics Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 52. Japan Prostate Cancer Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

Figure 53. Japan Prostate Cancer Therapeutics Drugs Sales Value by Sale Channel (%), 2023 VS 2030

Figure 54. South Korea Prostate Cancer Therapeutics Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 55. South Korea Prostate Cancer Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

Figure 56. South Korea Prostate Cancer Therapeutics Drugs Sales Value by Sale Channel (%), 2023 VS 2030

Figure 57. Southeast Asia Prostate Cancer Therapeutics Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 58. Southeast Asia Prostate Cancer Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

Figure 59. Southeast Asia Prostate Cancer Therapeutics Drugs Sales Value by Sale Channel (%), 2023 VS 2030

Figure 60. India Prostate Cancer Therapeutics Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 61. India Prostate Cancer Therapeutics Drugs Sales Value by Type (%), 2023 VS 2030

Figure 62. India Prostate Cancer Therapeutics Drugs Sales Value by Sale Channel (%), 2023 VS 2030

Figure 63. Prostate Cancer Therapeutics Drugs Industrial Chain

Figure 64. Prostate Cancer Therapeutics Drugs Manufacturing Cost Structure

Figure 65. Channels of Distribution (Direct Sales, and Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Advanced Prostate Cancer Drug Market Research Report 2025

Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024

Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prostate Cancer Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Diagnosis and Therapy Market Research Report 2024

Lung Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Precision Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Castration resistant Prostate Cancer Drugs Market Research Report 2025

Breast Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oncology Anti cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Tumor Immunotherapy Market

Lung Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Testicular Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Personalizing Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Solid Tumor Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Generics Market

Oral Cancer Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

[email protected]

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

	
		OSZAR »